College of Veterinary Medicine , Northwest A&F University , Yangling , Shaanxi 712100 , People's Republic of China.
J Agric Food Chem. 2018 Jun 13;66(23):5812-5820. doi: 10.1021/acs.jafc.8b00826. Epub 2018 May 29.
Reactive dicarbonyl species (RCS) such as methylglyoxal (MGO) and glyoxal (GO) are common intermediates in protein damage, leading to the formation of advanced glycation end products (AGEs) through nonenzymatic glycation. (+)-Catechin, a natural plant extract from tea, has been evaluated for its ability in trapping GO and MGO. However, (+)-catechin is also reported to have both antioxidant ability and pro-oxidant properties. Until now, whether (+)-catechin can inhibit the formation of nonenzymatic glycation and the mechanism of the inhibition in nucleoprotein nonenzymatic glycation is still unclear. In the present study, histone H1 and MGO were used to establish an in vitro (100 mM phosphate buffer solution (PBS), pH 7.4, 37 °C) protein glycation model to study the trapping ability of (+)-catechin. Our data show that MGO caused dose-dependent protein damage, and the content of MGO-induced Schiff base formation was inhibited by (+)-catechin when the molecular ratio of catechin:MGO was 1:6. The formation of N-carboxymethyllysine (CML) was reduced significantly when the ratio of (+)-catechin and MGO was 1:1, which was similar to the inhibition effect of aminoguanidine (AG). The formation of CML under in vitro conditions can be inhibited by low concentration (12.5-100 μM) of (+)-catechin but not with high concentration (200-800 μM) of (+)-catechin. The reason is that the high concentration of (+)-catechin did not inhibit CML formations due to HO produced by (+)-catechin. In the presence of catalase, catechin can inhibit MGO-induced CML formation. In conclusion, the trapping ability of (+)-catechin may be more effective at the early stage of nonenzymatic glycation. However, a high concentration (200-800 μM) of (+)-catechin may not inhibit the formation of CML because it induced the increase of HO formation.
反应性二羰基化合物(RCS),如甲基乙二醛(MGO)和乙二醛(GO),是蛋白质损伤的常见中间产物,通过非酶糖化作用形成晚期糖基化终产物(AGEs)。(+)-儿茶素是一种来自茶叶的天然植物提取物,已被评估其捕获 GO 和 MGO 的能力。然而,(+)-儿茶素也具有抗氧化能力和促氧化剂特性。到目前为止,(+)-儿茶素是否可以抑制非酶糖化的形成以及抑制核蛋白非酶糖化的机制仍不清楚。在本研究中,组蛋白 H1 和 MGO 被用于建立体外(100mM 磷酸盐缓冲溶液(PBS),pH7.4,37°C)蛋白质糖化模型,以研究(+)-儿茶素的捕获能力。我们的数据表明,MGO 引起剂量依赖性蛋白质损伤,并且当儿茶素:MGO 的分子比为 1:6 时,(+)-儿茶素抑制了 MGO 诱导的席夫碱形成。当(+)-儿茶素和 MGO 的比例为 1:1 时,N-羧甲基赖氨酸(CML)的形成显著减少,这与氨基胍(AG)的抑制作用相似。在体外条件下,CML 的形成可以被低浓度(12.5-100μM)的(+)-儿茶素抑制,但不能被高浓度(200-800μM)的(+)-儿茶素抑制。原因是由于(+)-儿茶素产生的 HO,高浓度的(+)-儿茶素不会抑制 CML 的形成。在过氧化氢酶存在下,儿茶素可以抑制 MGO 诱导的 CML 形成。总之,(+)-儿茶素的捕获能力可能在非酶糖化的早期阶段更为有效。然而,高浓度(200-800μM)的(+)-儿茶素可能不会抑制 CML 的形成,因为它诱导了 HO 形成的增加。